Dalhousie University is pleased to announce it has entered into a master license agreement with Strem Chemicals Inc. of Newburyport, Massachusetts, USA, for the production, marketing and selling for research purposes of chemicals developed by Dalhousie researchers.
The first chemicals to be covered under this agreement are six novel catalysts developed by Dr. Mark Stradiotto in the department of chemistry. Dr. Stradiotto’s catalysts will be useful in a wide range of applications and will be listed in Strem’s catalogue and sold for research purposes. Dalhousie will retain rights to exclusively license any of the chemicals for commercial purposes.
“This marks the first step in the realization of economic value from the excellent research that Mark and his colleagues are carrying on in his laboratory,” said Dr. Ronald Layden, executive director of Industry Liaison and Innovation (ILI) at Dalhousie University. “We believe that Mark’s research has the potential to be of great value in the chemical industry and in particular in the pharmaceutical sector where catalysis is a very important issue due to FDA regulations for purity in new drugs. We are very pleased to begin what we hope will be a long and productive relationship with Strem Chemicals Inc. and one which we hope will lead to future commercial licenses and a greater awareness of the high calibre chemistry research being carried out at Dalhousie.”
Dr. Stradiotto received the 2006 Dalhousie Innovation Award (co-sponsored by Dalhousie University, the IWK Health Centre, CDHA, Innovacorp, and the Office of Economic Development of Nova Scotia), recognizing the potential of his research for commercial development and providing $50,000 to assist him with further work in that area. Dr. Stradiotto and ILI were also successful in two recent applications to the Springboard network for a total of $30,000 in funding for proof-of-principle work and patenting.
About Strem Chemicals Inc.
Strem Chemicals Inc. was established in 1964, and is a privately held company that manufactures and markets specialty chemicals of high purity. Its clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical, microelectronic and chemical / petrochemical industries.
About the Industry Liaison and Innovation Office (WWW.DALINNOVATION.COM)
Commercializes research at Dalhousie University, manages and facilitates collaborations between companies and university researchers and assists in the creation of spin-off ventures.
Located in Halifax, Nova Scotia, Canada since 1818, Dalhousie attracts students from around the world. It is a comprehensive, research-intensive university with more than 15,500 students. According to a survey conducted by The Scientist magazine, Dalhousie was named the best non-commercial scientific institute in which to work in Canada.
For more information, please contact:
Dr. Ronald Layden
Industry Liaison and Innovation
Halifax, Nova Scotia, November 21, 2006